Getting Serious about High U.S. Drug Prices

The U.S. pharma industry is under attack by executive order, with the latest salvo designed to ensure the Medicare Part B program pays the same price for drugs as similarly developed nations pay. That order joins others issued this summer, all aimed at high U.S. drug prices. These orders – all variants of previous orders and […]

Read More